Ignite Creation Date:
2024-05-06 @ 12:27 PM
Last Modification Date:
2024-10-26 @ 12:59 PM
Study NCT ID:
NCT03767348
Status:
RECRUITING
Last Update Posted:
2023-08-02
First Post:
2018-12-05
Brief Title:
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab
Sponsor:
Replimune Inc
Organization:
Replimune Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| NSCLC |
| Cancer |
| Melanoma Skin |
| Mismatch Repair Deficiency |
| Microsatellite Instability |
| Non-melanoma Skin Cancer |
| Cutaneous Melanoma |